跳转至内容
Merck
CN

567280

4-(3-羟丙基)吗啉

95%

别名:

3-(4-吗啉)-1-丙醇, 3-吗啉代-1-丙醇

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C7H15NO2
化学文摘社编号:
分子量:
145.20
UNSPSC Code:
12352100
PubChem Substance ID:
MDL number:
Assay:
95%
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI

1S/C7H15NO2/c9-5-1-2-8-3-6-10-7-4-8/h9H,1-7H2

SMILES string

OCCCN1CCOCC1

InChI key

VZKSLWJLGAGPIU-UHFFFAOYSA-N

assay

95%

impurities

may contain ~5% morpholine

refractive index

n20/D 1.4770 (lit.)

bp

240-241 °C (lit.)

density

1.049 g/mL at 25 °C (lit.)

Application

4-(3-Hydroxypropyl)morpholine may be used in the synthesis of macrocyclic urea compounds, which can act as potent Chk1 inhibitors.

pictograms

Health hazardCorrosion

signalword

Danger

Hazard Classifications

Eye Dam. 1 - Repr. 2 - Skin Corr. 1B

存储类别

8A - Combustible corrosive hazardous materials

wgk

WGK 3

flash_point_f

185.0 °F - closed cup

flash_point_c

85 °C - closed cup

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

"Synthesis and in-vitro biological activity of macrocyclic urea Chk1 inhibitors"
Li J, et al.
Bioorganic & Medicinal Chemistry Letters, 17(23), 6499-6504 (2007)
David Johansson et al.
BMC cancer, 9, 67-67 (2009-02-28)
The prerequisite for the potential use of the bacterial toxin verotoxin-1 in the treatment of breast cancer was investigated by first determining the expression of its receptor Gb3 (CD77) in clinical breast cancer tissue specimens. We then examined the cytotoxicity
Y Jiang et al.
Journal of biological regulators and homeostatic agents, 34(6), 2029-2036 (2020-12-12)
Dysregulation of the adipo-osteogenic differentiation balance of mesenchymal stem cells (MSCs), which are common progenitor cells of adipocytes and osteoblasts, has been associated with many pathophysiologic diseases, such as obesity, osteopenia, and several neurodegenerative disorders. Growing evidence suggests that lipid
Weihong Xu et al.
Biochemical and biophysical research communications, 463(4), 545-550 (2015-06-01)
In the current study, we investigated the potential activity of AR-42, a novel histone deacetylase (HDAC) inhibitor, against colon cancer cells. Our in vitro results showed that AR-42 induced ceramide production, exerted potent anti-proliferative and pro-apoptotic activities in established (SW-620 and

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持